Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phase Ib study on the humanized anti-CCR4 antibody, KW-0761, in advanced solid tumors. | Nagoya J Med Sci | 2021 | 34916725 | PubTator, text mining | PubMed |
| Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma. | J Immunother Cancer | 2021 | 34916256 | PubTator, text mining | PubMed |
| DNA methylation of ARHGAP30 is negatively associated with ARHGAP30 expression in lung adenocarcinoma, which reduces tumor immunity and is detrimental to patient survival. | Aging (Albany NY) | 2021 | 34910688 | PubTator, text mining | PubMed |
| Bath Psoralen Plus UVA Therapy Suppresses Keratinocyte-Derived Chemokines in Pathogenetically Relevant Cells. | JID Innov | 2021 | 34909726 | PubTator, text mining | PubMed |
| Single cell analysis of spondyloarthritis regulatory T cells identifies distinct synovial gene expression patterns and clonal fates. | Commun Biol | 2021 | 34907325 | PubTator, text mining | PubMed |
| Exploring the Prognostic Value, Immune Implication and Biological Function of H2AFY Gene in Hepatocellular Carcinoma. | Front Immunol | 2021 | 34899687 | PubTator, text mining | PubMed |
| Application and prospects of single cell sequencing in tumors. | Biomark Res | 2021 | 34895349 | PubTator, text mining | PubMed |
| Identification of prognostic and therapeutic value of CC chemokines in Urothelial bladder cancer: evidence from comprehensive bioinformatic analysis. | BMC Urol | 2021 | 34893045 | PubTator, text mining | PubMed |
| Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. | Front Immunol | 2021 | 34887858 | PubTator, text mining | PubMed |
| Multifaceted Roles of Chemokines and Chemokine Receptors in Tumor Immunity. | Cancers (Basel) | 2021 | 34885241 | PubTator, text mining | PubMed |
| PCSK9 Imperceptibly Affects Chemokine Receptor Expression In Vitro and In Vivo. | Int J Mol Sci | 2021 | 34884827 | PubTator, text mining | PubMed |
| The Immunotherapy for Colorectal Cancer, Lung Cancer and Pancreatic Cancer. | Int J Mol Sci | 2021 | 34884642 | PubTator, text mining | PubMed |
| Prevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancer. | Sci Transl Med | 2021 | 34878821 | PubTator, text mining | PubMed |
| Chemokine receptor 8 expression may be linked to disease severity and elevated interleukin 6 secretion in acute pancreatitis. | World J Gastrointest Pathophysiol | 2021 | 34877026 | PubTator, text mining | PubMed |
| High expression of eIF4E is associated with tumor macrophage infiltration and leads to poor prognosis in breast cancer. | BMC Cancer | 2021 | 34876062 | PubTator, text mining | PubMed |
| Prognostic Potential of Secreted Modular Calcium-Binding Protein 1 in Low-Grade Glioma. | Front Mol Biosci | 2021 | 34869577 | PubTator, text mining | PubMed |
| Research Progress on the Role of Regulatory T Cell in Tumor Microenvironment in the Treatment of Breast Cancer. | Front Oncol | 2021 | 34868991 | PubTator, text mining | PubMed |
| A New Risk Score Based on Eight Hepatocellular Carcinoma- Immune Gene Expression Can Predict the Prognosis of the Patients. | Front Oncol | 2021 | 34868990 | PubTator, text mining | PubMed |
| ACSL4 Expression Is Associated With CD8+ T Cell Infiltration and Immune Response in Bladder Cancer. | Front Oncol | 2021 | 34868963 | PubTator, text mining | PubMed |
| Pushing Past the Blockade: Advancements in T Cell-Based Cancer Immunotherapies. | Front Immunol | 2021 | 34868044 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers?page=42